Shandong Sinocera Functional Material Co., Ltd. (SINOCERA) financials
SHZ · Basic Materials · Chemicals - Specialty · 5,170 employees · CEO Xi Yun Huo
- Price
- CN¥38.55 +3.35%
- Market cap
- CN¥38.4B
- Enterprise value
- CN¥39.4B
- Last report
- Q3 '26 filed 2026-09-30
- Next report
- 2027-04-22 EPS est. CN¥0.18
Valuation & key figures
- Market cap
- CN¥38.4B EV CN¥39.4B
- Revenue
- CN¥5.38B Trailing 12 months
- Revenue growth
- +21% FY2026 consensus
- Profit margin
- 12.4% Net income / revenue, TTM
- P/E
- 58.4× Forward 48.6× (FY2026)
- P/S
- 7.1× Price / sales, TTM
- EV / EBITDA
- 38.1× TTM
- Free cash flow
- CN¥55.1M Trailing 12 months
- Net income
- CN¥666M Trailing 12 months
- Revenue estimate
- CN¥5.53B FY2026 consensus
- Earnings
- 2027-04-22 Revenue est. CN¥1.46B
- Dividend
- CN¥0.15 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-26): revenue missed by 2.3%, EPS missed by 23.4%Revenue CN¥1.56B vs CN¥1.59B expected (-2.3%); EPS CN¥0.18 vs CN¥0.23 (-23.4%).
- Revenue growth accelerating: 38.7% year on yearQ3 '26 revenue CN¥1.57B, against an average of 15.9% over the four quarters before.
- Operating margin 14.1% (TTM), -4.2 pp on a year agoOperating income grew -4.8% while revenue grew 23.2%.
- Capex 14.7% of revenue (a year ago 6.7%)CN¥792M invested in the last 4 quarters (+172.9% on a year earlier). Free cash flow CN¥55.1M = 8.3% of net income.
- Returned CN¥135M to shareholders = 245.8% of free cash flowBuybacks CN¥0 (a year earlier CN¥102M), dividends CN¥135M, stock-based pay CN¥0 (TTM). More than the free cash flow: paid from cash or debt.
- Diluted share count down 0.3% in a year988M diluted shares in Q3 '26, 991M a year earlier.
- Net debt CN¥976MCash + short-term investments CN¥507M, debt incl. leases CN¥1.48B; a year ago net debt CN¥21.3M.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | CN¥1.57B | CN¥1.13B | +38.7% |
| Gross margin | 36.8% | 37.7% | -0.9 pp |
| Operating income | CN¥222M | CN¥202M | +10.1% |
| Operating margin | 14.2% | 17.8% | -3.7 pp |
| Net income | CN¥183M | CN¥158M | +15.8% |
| Diluted EPS | CN¥0.18 | CN¥0.16 | +12.5% |
| Operating cash flow | CN¥209M | CN¥289M | -27.6% |
| Capex | CN¥208M | CN¥104M | +99.9% |
| Free cash flow | CN¥1.13M | CN¥185M | -99.4% |
| R&D | CN¥108M | CN¥86M | +26.1% |
| Stock-based compensation | CN¥0 | CN¥0 | – |
Reported vs consensus
2026-10-26| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | CN¥1.56B | CN¥1.59B | -2.3% |
| EPS (as estimated) | CN¥0.18 | CN¥0.23 | -23.4% |
From the report of 2026-10-26 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- CN¥847M
- Capex
- -CN¥792M
- Buybacks
- CN¥0
- Dividends
- -CN¥135M
- Acquisitions
- -CN¥723M
- Net debt issued
- CN¥534M
- Stock-based compensation
- CN¥0
- Free cash flow
- CN¥55.1M
- Returned to shareholders / FCF
- 245.8%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 58.4× | 44.3× | 27.9× – 55.1× |
| EV / EBITDA | 38.1× | 28.4× | 15.8× – 38.7× |
| EV / Sales | 7.3× | 7.5× | 4.1× – 12.9× |
| Price / FCF | 698.0× | 401.5× 4 of 5 years | 44.9× – 1,384.7× |
| Price / Book | 5.1× | 4.4× | 2.5× – 7.4× |
| FCF yield | 0.1% | 0.7% | -1.2% – 2.2% |
| Return on invested capital | 6.8% | 8.9% | 7.3% – 12.0% |
| Return on equity | 9.1% | 9.8% | 8.5% – 13.8% |
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | CN¥5.53B | +21.3% | CN¥0.79 | +28.0% | 48.6× | 4 |
| FY2027 | CN¥6.84B | +23.7% | CN¥1.08 | +35.9% | 35.7× | 6 |
| FY2028 | CN¥8.08B | +18.2% | CN¥1.31 | +21.3% | 29.4× | 6 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02